Unknown

Dataset Information

0

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis.

ABSTRACT: People exposed to COVID-19 have a risk of developing disease, and health care workers are at risk at a time when they are badly needed during a health care crisis. Hydroxychloroquine and chloroquine have been used as treatment and are being considered as prophylaxis. Our patient developed COVID-19 while on hydroxychloroquine and although more work is needed, this calls into question the role of these medications as preventive therapy.

SUBMITTER: Dousa KM 

PROVIDER: S-EPMC7185003 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis.

Dousa Khalid M KM   Malavade Sharad S SS   Furin Jennifer J   Gripshover Barbara B   Hatszegi Marjorie M   Hojat Leila L   Saade Elie E   Salata Robert A RA  

IDCases 20200427

People exposed to COVID-19 have a risk of developing disease, and health care workers are at risk at a time when they are badly needed during a health care crisis. Hydroxychloroquine and chloroquine have been used as treatment and are being considered as prophylaxis. Our patient developed COVID-19 while on hydroxychloroquine and although more work is needed, this calls into question the role of these medications as preventive therapy. ...[more]

Similar Datasets

Unknown Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials.
| S-EPMC7489223 | biostudies-literature
Unknown Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
| S-EPMC7836824 | biostudies-literature
Unknown Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
| S-EPMC7441799 | biostudies-literature
Unknown Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.
| S-EPMC7714406 | biostudies-literature
Unknown Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
Unknown Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials Hidroxicloroquina como profilaxis para la infeccion por coronavirus SARS-CoV-2: revision de los ensayos clinicos en curso
| S-EPMC7261447 | biostudies-literature
Clinical A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
| 12454 | ecrin-mdr-crc
Unknown Opposing activities of IFITM proteins in SARS-CoV-2 infection
| S-SCDT-EMBOJ-2020-106501 | biostudies-other
Transcriptomics SHAE002: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures.
2013-07-31 | E-GEOD-47960 | biostudies-arrayexpress
Transcriptomics SHAE003: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures.
2013-07-31 | E-GEOD-47961 | biostudies-arrayexpress